Cargando…
HER2 status and disparities in luminal breast cancers
National Comprehensive Care Network guidelines for adjuvant treatment of invasive breast cancer are based on HER2 and hormone receptor (HR) status, where HR+ disease encompasses all estrogen receptor (ER)+ and/or progesterone receptor (PR)+ tumors. We sought to explore clinical and demographic diffe...
Autores principales: | Holowatyj, Andreana N., Ruterbusch, Julie J., Ratnam, Manohar, Gorski, David H., Cote, Michele L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893351/ https://www.ncbi.nlm.nih.gov/pubmed/27250116 http://dx.doi.org/10.1002/cam4.757 |
Ejemplares similares
-
Renal cell carcinoma risk associated with lower intake of micronutrients
por: Bock, Cathryn H., et al.
Publicado: (2018) -
Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
por: Malburg, Carly M., et al.
Publicado: (2020) -
Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status
por: Ma, Huiyan, et al.
Publicado: (2015) -
Cancer survival disparities by health insurance status
por: Niu, Xiaoling, et al.
Publicado: (2013) -
Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
por: Beebe‐Dimmer, Jennifer L., et al.
Publicado: (2019)